Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT02405754 Completed - Clinical trials for Coronary Artery Disease

Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

AACU
Start date: February 2014
Phase:
Study type: Observational

This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investigator. Limited demographic data and patient data pertaining to cardiology referral or advanced diagnostic testing will be collected. All data will be collected anonymously.

NCT ID: NCT02394938 Completed - Heart Diseases Clinical Trials

Effects of Recorded Music in Heart Failure Patients

EMSC
Start date: March 2015
Phase: N/A
Study type: Interventional

Aims. To describe a new conceptual framework and to test the effectiveness of a recorded music listening protocol on symptom burden and quality of life in heart failure patients.

NCT ID: NCT02389946 Completed - Clinical trials for Coronary Artery Disease

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

BIOFLOW-V
Start date: May 2015
Phase: N/A
Study type: Interventional

The objective of this study is to assess the safety and efficacy of the Orsiro Sirolimus Eluting Coronary Stent System in the treatment of subjects with up to three native de novo or restenotic (standard PTCA only) coronary artery lesions compared to the Xience coronary stent system.

NCT ID: NCT02389491 Completed - Clinical trials for Congenital Heart Disease

Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants

CHD
Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the effects of high density formula in early postoperative infants with congenital heart disease and to assess its safety.

NCT ID: NCT02389153 Completed - Clinical trials for Coronary Heart Disease

Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease

Start date: July 2014
Phase: N/A
Study type: Interventional

The main focus of the pilot study is to evaluate the feasability and effectiveness of a collaborative care intervention for patients suffering from a coronary heart disease (CHD) with insufficient controlled health related risk factors in their lifestyle. The design of the study is a wait list control design. 30 patients will receive treatment immediately after submission, the other 30 after 6 months. An interdisciplinary team, including a care manager for each patient, will offer an individualized treatment plan, based on shared decision making for each patient to reduce risk factors and improve quality of life.

NCT ID: NCT02387944 Completed - Clinical trials for Congenital Heart Defect

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease

POCHEMO
Start date: March 2015
Phase: N/A
Study type: Observational

The purpose of this study is to assess coagulation and platelet function in children with congenital heart disease, measured with a bedside device (thromboelastometry and impedance aggregometry). The investigators also aim to determine if this device detect post-cardiopulmonary bypass clotting derangements and may help to manage bleeding in this population.

NCT ID: NCT02378857 Completed - Clinical trials for Congenital Heart Disease

Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects

Start date: March 2015
Phase:
Study type: Observational

Cross-sectional study of a national cohort of adolescents with univentricular congenital heart defects and Fontan type palliation.

NCT ID: NCT02376244 Completed - Heart Disease Clinical Trials

The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation

Start date: September 2015
Phase: N/A
Study type: Interventional

Cardiac rehabilitation is a program designed to help patients regain good health through lifestyle change after a heart attack, heart surgery or other heart problems. Patients will take part in exercise sessions and education lessons, tailored to meet their personal needs. The exercise training component of cardiac rehabilitation may be delivered as intervals of short intense sessions (also known as high intensity intervals) or the current standard care of longer but less intense sessions (moderate intense intervals). Both exercises have been shown to increase fitness levels and also prevent future risk of heart disease. The purpose of this study is to determine the efficacy and safety of high intensity interval exercise training (HIIT) in patients who had a recent cardiac revascularization procedure or recovering from a heart attack, in comparison to current standard of moderate intensity exercise training in terms of their physical fitness and psychological well-being.

NCT ID: NCT02360397 Completed - Myocardial Ischemia Clinical Trials

Ranolazine Mediated PVC Reduction in Ischemic Heart Disease

Start date: December 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether ranolazine has beneficial effects on cardiac ischemia through reduction of premature ventricular contraction burden.

NCT ID: NCT02354040 Completed - Clinical trials for Coronary Artery Disease

Using a Tailored Health Information Technology Driven Intervention to Improve Health Literacy and Medication Adherence

TalkingRx
Start date: April 2015
Phase: N/A
Study type: Interventional

Although most patients admitted with acute coronary syndrome or acute ischemic stroke in South Asian countries receive these evidence-based treatments, their overall continuation in the outpatient phase of care remains low. Patient from Pakistan are uniquely challenged in this respect because the overall literacy rates remain one of the lowest in Pakistan among South Asian Countries. In addition, a great majority of Pakistani patients often do not understand or follow health prescriptions (which are still written in English). Additionally, due to an unregulated health industry, they frequently take multiple opinions and prescriptions from different physicians. The investigators propose to develop a "talking prescription" for patients with stroke or myocardial infarction for secondary prevention. This will enable them to understand their medications better, improve health literacy and adherence. This is an IT enabled health literacy intervention. Physicians will prescribe statin and/or antiplatelet to the selected patients and enter the necessary details on an Optical Mark Recognition (OMR) sheet.Patients will be assigned to either of the 2 arms--either regular care or talking prescriptions. Follow-up will be done at 3 months post recruitment for behavioral knowledge assessment and adherence assessment.